BioSpace News Archive

Business

Acer Therapeutics Reports Q3 2021 Financial Results and Provides Corporate Update

Acer Therapeutics Inc. today reported financial results for the third quarter ended September 30, 2021 and provided an update on Acer’s recent corporate developments.

November 19, 2021
·
11 min read
Genetown

EyePoint Pharmaceuticals Announces Closing of $115.4 Million Public Offering

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), today announced the closing of the previously announced underwritten public offering of 5,122,273 shares of its common stock.

November 19, 2021
·
4 min read
Biotech Bay

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Nov 19, 2021

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare disease, announced, as required by Nasdaq Stock Market rules, the grant of inducement awards to a new employee.

November 19, 2021
·
1 min read
Business

Adamis Pharmaceuticals Schedules Financial Results Conference Call and Business Update

Adamis Pharmaceuticals Corporation today announced that it will host an investor conference call on Monday, November 22, 2021 at 2 p.m. Pacific Time to discuss its financial and operating results for the first nine months of 2021, as well as provide a business update.

November 19, 2021
·
2 min read
Biotech Beach

Xencor to Present at Upcoming Investor Conferences - Nov 19, 2021

Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, announced that company management will participate at two upcoming investor conferences.

November 19, 2021
·
1 min read
Drug Development

Amzell, B.V., in Collaboration With Amring Pharmaceuticals Inc. Announce Their Lead Product Has Entered Phase III Clinical Trial in the U.S. for Treatment of Infantile Epileptic Disease

Amzell, B.V. and Amring Pharmaceuticals Inc. announced today that their lead product in the collaboration, AMZ002, has entered Phase III Clinical Trial in the U.S. for treatment of infantile epileptic disease.

November 19, 2021
·
3 min read
Biotech Beach

Quidel Presents at 33rd Annual Piper Sandler Healthcare Conference

Quidel Presents at 33rd Annual Piper Sandler Healthcare Conference.

November 19, 2021
·
1 min read
Drug Development

ASRA 2021 | Cali Biosciences Presents Phase IIa Clinical Data on CPL-01, a Long-Acting Ropivacaine

Cali Biosciences, a global biopharmaceutical company focused on the research and development of innovative drugs, presented Phase IIa clinical data on its perioperative long-acting ropivacaine, CPL- 01, at the 20th Annual American Society of Regional Anesthesia and Pain Medicine Meeting.

November 19, 2021
·
2 min read
Stretcher Chairs Market Research by Growth, Competitive Methods and Forecast to 2026

The healthcare industry has witnessed a key development with the advancements in stretcher chairs. These advancements enable clinicians to serve patients in emergencies.

November 19, 2021
·
5 min read
Surgical Drapes Market | Know the Strategies to Increase the Growth Avenues in the Upcoming Years

The surgical drapes market has been projected to grow at a significant pace in the forthcoming years. This market growth can be attributed to the growing number of surgical procedures along with rising cases of chronic diseases.

November 19, 2021
·
4 min read